Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021Business Wire • 11/01/21
Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical ResearchBusiness Wire • 10/13/21
Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data StorageBusiness Wire • 10/12/21
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare DiseasesBusiness Wire • 10/06/21
Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance OfficerBusiness Wire • 09/27/21
Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical StudiesBusiness Wire • 09/23/21
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library DesignBusiness Wire • 09/23/21
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19Business Wire • 09/14/21
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer TherapeuticsBusiness Wire • 09/13/21
Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research ProgramsBenzinga • 09/09/21
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery CollaborationBusiness Wire • 09/09/21
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodiesGlobeNewsWire • 08/18/21
Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 GuidanceBenzinga • 08/06/21
Twist Bioscience Corp. (TWST) CEO Emily Leproust on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/06/21
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of DirectorsBusiness Wire • 08/06/21